Publication | Closed Access
Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab
101
Citations
28
References
2017
Year
Routine Blood CountCancer ImmunosurveillanceOncologyAutoimmune DiseaseMalignant Blood DisorderMelanomaImmunologyHematologyImmune SurveillanceAutoimmunityImmune Checkpoint InhibitorMelanoma PatientsImmunotherapyMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1